Dynamical Biomarkers Group
In Taiwan universal healthcare is available to all, so we deeply understand the urgency in controlling the cost and wise use of medical resources. Furthermore, in the greater China region, providing quality healthcare in rural areas also poses an incredible challenge. The Dynamical Biomarkers Group (DBG) is a research group of the Center for Dynamical Biomarkers and Translational Medicine at National Central University in Taiwan. DBG is comprised of a multidisciplinary team of clinicians, scientists and engineers, that are devoted to addressing these healthcare challenges. The goal of the Qualcomm Tricorder XPRIZE is in line with the mission of our group, and it provides a wonderful opportunity for us to develop the disruptive innovations that are needed. DBG is sponsored by HTC, a global leader in innovation and design.
Dynamical Biomarkers Group has developed a system of three modules: Smart Vital-Sense Monitor; Smart Blood-Urine Test Kit; Smart Scope Module. These modules incorporated innovative hardware, technologies for physiologic signal analysis, image processing, biomarker detection. They have each been designed to allow consumers to use them in a simple and intuitive way, as they are wirelessly connected to a smartphone, which runs a user-friendly app with an intelligent and interactive screening process that guides the users to carry out specific tests to generate disease diagnosis.
About Team Leader
Chung-Kang Peng, Ph.D., is the founding Dean of the College of Health Sciences and Technology, and K.-T. Li Chair Professor of the National Central University in Taiwan. He is also the Director of the Center for Dynamical Biomarkers at the Beth Israel Deaconess Medical Center / Harvard Medical School.
Terry B.J. Kuo
Norden E. Huang
Andrew C. Ahn